Furthermore, the models identified metabolic patterns that are associated with three gene variants (PNPLA3, TM6SF2, and HSD17B13) linked to NAFLD, providing insights into metabolic dysregulation in the liver and its contribution towards NAFLD progression. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.